Literature DB >> 16669854

Access to emergency hormonal contraception from community pharmacies and family planning clinics.

Gaye Lewington1, Kay Marshall.   

Abstract

AIMS: To evaluate differences in the time taken to access progestogen-only emergency hormonal contraception (EHC) by young women from family planning (FP) or community pharmacy settings.
METHODS: An observational study of 203 women requesting EHC from FP clinics and community pharmacies in South-west Kent Primary Care Trust (PCT) from December 2002 to October 2003.
RESULTS: Access to EHC from community pharmacy was significantly faster than from FP clinics (16 h vs. 41 h, P<0.001). Older teenagers tended to seek EHC more quickly and were more likely to have had a contraceptive failure rather than have used no contraception at all.
CONCLUSION: The results provide further support for pharmacist involvement in the supply of EHC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16669854      PMCID: PMC1885065          DOI: 10.1111/j.1365-2125.2006.02623.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task Force on Postovulatory Methods of Fertility Regulation.

Authors:  G Piaggio; H von Hertzen; D A Grimes; P F Van Look
Journal:  Lancet       Date:  1999-02-27       Impact factor: 79.321

2.  Emergency contraception: lessons learned from the UK.

Authors:  Katie D Schenk
Journal:  J Fam Plann Reprod Health Care       Date:  2003-04

3.  Supplying emergency contraception via community pharmacies in the UK: reflections on the experiences of users and providers.

Authors:  Paul Bissell; Claire Anderson
Journal:  Soc Sci Med       Date:  2003-12       Impact factor: 4.634

4.  Trends in the use of emergency contraception: an epidemiological study in Barcelona, Spain (1994-2002).

Authors:  M A Checa; J Pascual; A Robles; R Carreras
Journal:  Contraception       Date:  2004-09       Impact factor: 3.375

5.  Advanced provision of emergency contraception does not reduce abortion rates.

Authors:  Anna Glasier; Karen Fairhurst; Sally Wyke; Sue Ziebland; Peter Seaman; Jeremy Walker; Fatim Lakha
Journal:  Contraception       Date:  2004-05       Impact factor: 3.375

6.  Placing emergency contraception in the hands of women.

Authors:  Iris F Litt
Journal:  JAMA       Date:  2005-01-05       Impact factor: 56.272

7.  Knowledge and use of secondary contraception among patients requesting termination of pregnancy.

Authors:  D R Bromham; R S Cartmill
Journal:  BMJ       Date:  1993-02-27

8.  Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial.

Authors:  Tina R Raine; Cynthia C Harper; Corinne H Rocca; Richard Fischer; Nancy Padian; Jeffrey D Klausner; Philip D Darney
Journal:  JAMA       Date:  2005-01-05       Impact factor: 56.272

9.  Evaluation of an emergency contraception advance provision service.

Authors:  Kelly Blanchard; Hilary Bungay; Ann Furedi; Lesley Sanders
Journal:  Contraception       Date:  2003-05       Impact factor: 3.375

10.  A qualitative study of pharmacists' perspectives on the supply of emergency hormonal contraception via patient group direction in the UK.

Authors:  Paul Bissell; Imogen Savage; Claire Anderson
Journal:  Contraception       Date:  2005-10-20       Impact factor: 3.375

View more
  3 in total

1.  A prescription for better prescribing.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

2.  Women's preferences for the provision of emergency hormonal contraception services.

Authors:  Elizabeth M Seston; Rachel A Elliott; Peter R Noyce; Katherine Payne
Journal:  Pharm World Sci       Date:  2007-02-06

3.  The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England.

Authors:  Adam Todd; Alison Copeland; Andy Husband; Adetayo Kasim; Clare Bambra
Journal:  BMJ Open       Date:  2014-08-12       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.